| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 4 | 
| NetGPI | no | yes: 0, no: 5 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 | 
| GO:0110165 | cellular anatomical entity | 1 | 5 | 
Related structures:
AlphaFold database: Q4Q7S0
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 186 | 190 | PF00656 | 0.740 | 
| CLV_C14_Caspase3-7 | 61 | 65 | PF00656 | 0.501 | 
| CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.504 | 
| CLV_NRD_NRD_1 | 242 | 244 | PF00675 | 0.539 | 
| CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.576 | 
| CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.504 | 
| CLV_PCSK_KEX2_1 | 242 | 244 | PF00082 | 0.539 | 
| CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.474 | 
| DEG_Kelch_Keap1_1 | 145 | 150 | PF01344 | 0.745 | 
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.689 | 
| DEG_SCF_FBW7_1 | 215 | 222 | PF00400 | 0.749 | 
| DEG_SCF_TRCP1_1 | 68 | 74 | PF00400 | 0.546 | 
| DOC_CKS1_1 | 161 | 166 | PF01111 | 0.756 | 
| DOC_MAPK_gen_1 | 230 | 238 | PF00069 | 0.646 | 
| DOC_MAPK_MEF2A_6 | 11 | 19 | PF00069 | 0.658 | 
| DOC_MAPK_MEF2A_6 | 95 | 103 | PF00069 | 0.375 | 
| DOC_PP2B_LxvP_1 | 211 | 214 | PF13499 | 0.722 | 
| DOC_PP4_FxxP_1 | 212 | 215 | PF00568 | 0.763 | 
| DOC_PP4_MxPP_1 | 169 | 172 | PF00568 | 0.720 | 
| DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.346 | 
| DOC_USP7_MATH_1 | 45 | 49 | PF00917 | 0.473 | 
| DOC_WW_Pin1_4 | 160 | 165 | PF00397 | 0.784 | 
| DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.673 | 
| DOC_WW_Pin1_4 | 215 | 220 | PF00397 | 0.790 | 
| DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.613 | 
| LIG_14-3-3_CanoR_1 | 235 | 239 | PF00244 | 0.804 | 
| LIG_Actin_WH2_2 | 6 | 22 | PF00022 | 0.656 | 
| LIG_BRCT_BRCA1_1 | 206 | 210 | PF00533 | 0.742 | 
| LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.681 | 
| LIG_deltaCOP1_diTrp_1 | 87 | 96 | PF00928 | 0.485 | 
| LIG_FHA_1 | 132 | 138 | PF00498 | 0.796 | 
| LIG_FHA_1 | 177 | 183 | PF00498 | 0.737 | 
| LIG_FHA_2 | 126 | 132 | PF00498 | 0.767 | 
| LIG_LIR_Apic_2 | 209 | 215 | PF02991 | 0.766 | 
| LIG_LIR_Gen_1 | 207 | 215 | PF02991 | 0.762 | 
| LIG_LIR_Gen_1 | 87 | 97 | PF02991 | 0.460 | 
| LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.710 | 
| LIG_LIR_Nem_3 | 207 | 213 | PF02991 | 0.765 | 
| LIG_LIR_Nem_3 | 87 | 92 | PF02991 | 0.516 | 
| LIG_LIR_Nem_3 | 93 | 99 | PF02991 | 0.357 | 
| LIG_NRP_CendR_1 | 247 | 250 | PF00754 | 0.534 | 
| LIG_Pex14_2 | 96 | 100 | PF04695 | 0.521 | 
| LIG_SH2_PTP2 | 161 | 164 | PF00017 | 0.690 | 
| LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.699 | 
| LIG_SH2_STAT5 | 161 | 164 | PF00017 | 0.690 | 
| LIG_SH3_1 | 167 | 173 | PF00018 | 0.706 | 
| LIG_SH3_3 | 167 | 173 | PF00018 | 0.706 | 
| LIG_SH3_3 | 72 | 78 | PF00018 | 0.585 | 
| LIG_SUMO_SIM_par_1 | 33 | 38 | PF11976 | 0.470 | 
| LIG_TRAF2_1 | 183 | 186 | PF00917 | 0.738 | 
| LIG_UBA3_1 | 12 | 16 | PF00899 | 0.638 | 
| MOD_CDK_SPK_2 | 160 | 165 | PF00069 | 0.757 | 
| MOD_CDK_SPxxK_3 | 160 | 167 | PF00069 | 0.754 | 
| MOD_CK1_1 | 129 | 135 | PF00069 | 0.783 | 
| MOD_CK1_1 | 136 | 142 | PF00069 | 0.731 | 
| MOD_CK1_1 | 143 | 149 | PF00069 | 0.668 | 
| MOD_CK1_1 | 151 | 157 | PF00069 | 0.655 | 
| MOD_CK1_1 | 204 | 210 | PF00069 | 0.802 | 
| MOD_CK1_1 | 234 | 240 | PF00069 | 0.773 | 
| MOD_CK1_1 | 38 | 44 | PF00069 | 0.551 | 
| MOD_CK1_1 | 47 | 53 | PF00069 | 0.487 | 
| MOD_CK1_1 | 5 | 11 | PF00069 | 0.630 | 
| MOD_CK1_1 | 58 | 64 | PF00069 | 0.388 | 
| MOD_CK1_1 | 66 | 72 | PF00069 | 0.449 | 
| MOD_CK1_1 | 76 | 82 | PF00069 | 0.487 | 
| MOD_CK2_1 | 129 | 135 | PF00069 | 0.783 | 
| MOD_CK2_1 | 144 | 150 | PF00069 | 0.659 | 
| MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.328 | 
| MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.612 | 
| MOD_GlcNHglycan | 37 | 40 | PF01048 | 0.733 | 
| MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.657 | 
| MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.602 | 
| MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.665 | 
| MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.669 | 
| MOD_GSK3_1 | 125 | 132 | PF00069 | 0.764 | 
| MOD_GSK3_1 | 135 | 142 | PF00069 | 0.701 | 
| MOD_GSK3_1 | 144 | 151 | PF00069 | 0.619 | 
| MOD_GSK3_1 | 201 | 208 | PF00069 | 0.800 | 
| MOD_GSK3_1 | 215 | 222 | PF00069 | 0.687 | 
| MOD_GSK3_1 | 234 | 241 | PF00069 | 0.780 | 
| MOD_GSK3_1 | 35 | 42 | PF00069 | 0.670 | 
| MOD_GSK3_1 | 44 | 51 | PF00069 | 0.469 | 
| MOD_N-GLC_1 | 204 | 209 | PF02516 | 0.586 | 
| MOD_N-GLC_1 | 90 | 95 | PF02516 | 0.684 | 
| MOD_NEK2_1 | 229 | 234 | PF00069 | 0.736 | 
| MOD_NEK2_1 | 238 | 243 | PF00069 | 0.798 | 
| MOD_PIKK_1 | 140 | 146 | PF00454 | 0.766 | 
| MOD_PKA_2 | 229 | 235 | PF00069 | 0.752 | 
| MOD_Plk_1 | 176 | 182 | PF00069 | 0.646 | 
| MOD_Plk_1 | 63 | 69 | PF00069 | 0.518 | 
| MOD_Plk_1 | 90 | 96 | PF00069 | 0.483 | 
| MOD_Plk_2-3 | 152 | 158 | PF00069 | 0.739 | 
| MOD_Plk_4 | 30 | 36 | PF00069 | 0.310 | 
| MOD_ProDKin_1 | 160 | 166 | PF00069 | 0.783 | 
| MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.666 | 
| MOD_ProDKin_1 | 215 | 221 | PF00069 | 0.793 | 
| MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.612 | 
| TRG_DiLeu_BaEn_2 | 205 | 211 | PF01217 | 0.742 | 
| TRG_DiLeu_BaLyEn_6 | 8 | 13 | PF01217 | 0.667 | 
| TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.754 | 
| TRG_ER_diArg_1 | 164 | 167 | PF00400 | 0.794 | 
| TRG_ER_diArg_1 | 229 | 231 | PF00400 | 0.667 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A3S7X330 | Leishmania donovani | 84% | 100% | 
| A4HHY6 | Leishmania braziliensis | 55% | 100% | 
| A4I566 | Leishmania infantum | 84% | 100% | 
| E9B0G3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 76% | 94% |